Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Spain
Lapatinib

AEMPS 2011

Lapatinib

Tyverb 250 MG Comprimidos Recubiertos con Pelicula

250 mg comprimido masticableSpainMarketedAuthorised 15 Mar 2011

Product informationAsk Osler about it

On this page

In other countries
Packs
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

TyverbEuropean Union · Novartis Europharm LimitedSame brand
TyverbCroatiaSame brand
TyverbItaly · Compressa rivestita con film · Novartis Europharm LimitedSame brand
TyverB, filmomhulde tablet 250 mgNetherlands · Filmomhulde tablet · Novartis Europharm LimitedSame brand
Tyverb®Serbia · 250mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
Tyverb®Serbia · 250mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
Tyverb®Serbia · 250mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand

More with the same substance on this register

Lapatinib Stada 250 MG Comprimidos Recubiertos con Pelicula EfgLapatinib · 250 mg · comprimido recubierto con películaSpain
Tyverb 250 MG Comprimidos Recubiertos con PeliculaLapatinib · 250 mg · comprimido recubierto con película

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇨🇦

TykerbCanada · 250 MG · Tablet · Novartis Pharmaceuticals Canada INC

Same form

🇭🇷Lapatinib Teva 250 mg filmom obložene tablete*Croatia · Filmom obložena tableta · TEVA GmbH, Graf-Arco-Str. 3, Ulm, NjemačkaSame form

🇳🇱Brastib 250 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Stada Arzneimittel AGSame form

🇳🇱Lapatinib PharOS 250 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Pharos Pharmaceutical Oriented Services LtdSame form

🇸🇦Tykerb 250MG F.C. TabletsSaudi Arabia · GlaxoSame form

🇸🇦Tykerb 250MG F.C. TabletsSaudi Arabia · Glaxo OperationSame form

Packs

Pack	Code	Status
TYVERB 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 140 comprimidos	665955

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS
Package leafletAEMPS
Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lapatinib
Strength: 250 mg
Dosage form: comprimido masticable
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 15 Mar 2011
Registration: 07440005
Marketing authorisation holder: Novartis Europharm Limited
Procedure: EU centralised
Supply: Diagnóstico Hospitalario

🇪🇸Spain